SKI Market

A+| A| A-|

Indian Indices

Sensex

76,009.70 -479.26
( -0.63%)

Global Indices

Nasdaq

50,600.70 294.03
(0.58%)

Dow Jones

7,494.47 27.75
(0.37%)

Hang Seng

64,932.04 -226.15
(-0.35%)

Nikkei 225

10,499.42 33.16
(0.32%)

Forex

USD-INR

95.61 -0.67
(-0.70%)

EUR-INR

110.97 -0.85
(-0.76%)

GBP-INR

128.43 -0.86
(-0.66%)

JPY-INR

0.60 0.00
(-0.79%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

356.2358719

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

59.7

10960.72

EPS(TTM)

Face Value()

Div & Yield %

19.92

0.42

Date	Headline
18-May-2026	Board of Strides Pharma Science recommends final dividend
18-May-2026	Strides Pharma Science consolidated net profit rises 54.45% in the March 2026 quarter
18-May-2026	Strides Pharma Q4 PAT rises 54% YoY to Rs 127 crore
12-May-2026	Strides Pharma Science to hold board meeting
05-Feb-2026	Strides Pharma receives USFDA inspection closure report for its Chestnut Ridge facility
30-Jan-2026	Strides Pharma Science consolidated net profit rises 129.80% in the December 2025 quarter
30-Jan-2026	Strides Pharma Science jumps after strong Q3 performance
24-Jan-2026	Strides Pharma Science to conduct board meeting
26-Dec-2025	Strides Pharma slides as US arm receives 4 USFDA observations for New York facility
03-Dec-2025	Strides Pharma Science announces change in senior management

<< < 1 2 > >>

76,009.70 -479.26 ( -0.63%)

50,600.70 294.03 (0.58%)

7,494.47 27.75 (0.37%)

64,932.04 -226.15 (-0.35%)

10,499.42 33.16 (0.32%)

95.61 -0.67 (-0.70%)

110.97 -0.85 (-0.76%)

128.43 -0.86 (-0.66%)

0.60 0.00 (-0.79%)